NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China
NMPA issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China (2019 No. 103).
The State Council's Leading Group for Deepening the Reform of the Medical and Health System Issued the Notice on Policies and Measures to Further Deepen the Reform of the Medical and Health System with Centralized Procurement & Use of Drugs as a Breakthrough
The Notice pointed out that it is necessary to promote the interlocked reform of health care, health insurance, and pharmaceuticals, magnify the effects of reform, and better address the problems complicating medical services to the people.
NMPA Issued the Notice on the Implementation Plan of the State Council for Full-Coverage Pilot Reform of Separated Management of Permit and License in the Free Trade Pilot Areas
NMPA issued a corresponding pilot implementation plan covering five parts:the guiding ideology, the scope and content of the pilot, the classified promotion of the reform of the examination and approval system,the improvement of the supporting measures for reform, and the effectiveimplementation of the reform policy.
NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions
NMPA has formulated,in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.
NMPA Issued the Announcement on Enabling the New Version of Management System for Import Filing of Drugs and Medicinal Materials
NMPA and the General Administration of Customs have collaboratively established a management system for import filing of pharmaceuticals and medicinal material imports.
NMPA issued the Notice on Enabling the Import and Export Permit Management System, which clearly states that the drug import and export permit management system has been officially launched since December 25, 2019.